HIV-1 and HIV-2 dual infection: Lack of HIV-2 provirus correlates with low CD4+ lymphocyte counts

AIDS

Volumn 12, Issue 2, 1998, Pages 131-137

  Sarr, Abdoulaye Dieng ^a   Hamel, Donald J ^a   Thior, Ibou ^a   Kokkotou, Efi ^a   Sankalé, Jean Louis ^a   Marlink, Richard G ^a   Coll Seck, Eva Marie ^b   Essex, Myron E ^a   Siby, Tidiane ^c   NDoye, Ibrahima ^d   Mboup, Souleymane ^c   Kanki, Phyllis J ^a  

^a Harvard AIDS Institute   (United States)

^b Fann University Teaching Hospital   (Senegal)

^c UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^d Institute for Social Hygiene   (Senegal)

Author keywords

Dual infection; HIV; Nested polymerase chain reaction

Indexed keywords

CD4 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; HOSPITAL PATIENT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTITUTION; SOUTHERN BLOTTING; VIROGENESIS;

BLOTTING, SOUTHERN; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; DNA, VIRAL; FEMALE; HIV ANTIBODIES; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; IMMUNOBLOTTING; POLYMERASE CHAIN REACTION; PROVIRUSES; SENSITIVITY AND SPECIFICITY;

EID: 6844250975     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199802000-00002     Document Type: Article

References (31)

1. Barin F, MBoup S, Denis F, et al.: Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa. Lancet 1985, ii:1387-1389.
2. Tedder RS, O'Connor T, Hughs A, Corrah T, Whittle H: Envelope cross-reactivity in Western blot for HIV-1 and HIV-2 may not indicate dual infection. Lancet 1988, ii:927.
3. World Health Organization: Proposed WHO criteria for interpreting results from Western blot assays for HIV-1, HIV-2, and HTLV-I/HTLV-II. Wkly Epidemiol Rec 1990, 65:281-283.
4. Gnann Jr JW, McCormick JB, Mitchell S, Nelson JA, Oldstone MBA: Synthetic peptides immunoassay distinguishes HIV type 1 and HIV type 2 infections. Science 1987, 237:1346-1349.
5. Broliden PA, Ruden U, Ouattara AS, et al.: Specific synthetic peptides for detection of and discrimination between HIV-1 and HIV-2 infection. J Acquir Immune Defic Syndr 1991, 4:952-958.
6. Baillou A, Janvier B, Leonard G, Denis F, Goudeau A, Barin F: Fine serotyping of human immunodeficiency virus serotype 1 (HIV-1) and HIV-2 infections by using synthetic oligopeptides representing an immunodominant domain of HIV-1 and HIV-2/simian immunodeficiency virus. J Clin Microbiol 1991, 29:1387-1391.
7. Evans LA, Moreau J, Odehouri K, et al.: Simultaneous isolation of HIV-1 and HIV-2 from an AIDS patient. Lancet 1988, ii:1389-1391.
8. Rayfield M, DeCock K, Heyward W, et al.: Mixed human immunodeficiency virus (HIV) infection in an individual: demonstration of both HIV type 1 and type 2 proviral sequence by using polymerase chain reaction. J Infect Dis 1988, 158:1170-1176.
9. Peeters M, Gershy-Damet GM, Fransen K, et al.: Virological and polymerase chain reaction studies of HIV-1/HIV-2 dual infection in Cote d'Ivoire. Lancet 1992, 340:339-340.
10. George JR, Ou C-Y, Parekh B, et al.: Prevalence of HIV-1 and HIV-2 mixed infections in Cote d'Ivoire. Lancet 1992, 340:337-339.
11. Léonard G, Chaput A, Courgnaud V, Sangaré A, Denis F, Brechot C: Characterization of dual HIV-1 and HIV-2 serological profiles by polymerase chain reaction. AIDS 1993, 7:1185-1189.
12. Kanki P, MBoup S, Marlink R, et al.: Prevalence and risk determinants of human immunodeficiency virus type 2 (HIV-2) and human immunodeficiency virus type 1 (HIV-1) in west African female prostitutes. Am H Epidemiol 1992, 136:895-907.
13. Kanki PJ, Travers K, MBoup S, et al.: Slower heterosexual spread of HIV-2 than HIV-1. Lancet 1994, 343:943-946.
14. Guèye-Ndiaye A, Clark RJ, Samuel KP, et al.: Cost-effective diagnosis of HIV-1 and HIV-2 by recombinant-expressed env peptide (566/966) dot blot analysis. AIDS 1993, 7:475-481.
15. Travers K, MBoup S, Marlink R, et al.: Natural protection against HIV-1 infection provided by HIV-2. Science 1995, 268:1612-1615.
16. Centers for Disease Control: Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992, 41/RR-17:1-19.
17. Simmonds P, Balfe P, Peutherer JF, Ludlam CA, Bishop JO, Brown AJ: Human immunodeficiency-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J Virol 1990, 64:864-872.
18. Grankvist O, Bredberg-Raden U, Gusstafsson A, et al.: Improved detection of HIV-2 DNA in clinical samples using nested primer-based polymerase chain reaction. J Acquir Immune Defic Syndr 1992, 5:286-293.
19. Fisher AG, Collalti E, Ratner L, Gallo RC, Wong-Staal F: A molecular clone of HTLV-III with biological activity. Nature 1985, 316:262-265.
20. AGM. J Virol 1990, 64:742-747.
21. Albert J, Fenyo E-M: Simple, sensitive and specific detection of human immunodeficiency virus type 1 in clinical speciments by polymerase chain reaction with nested primers. J Clin Microbiol 1990, 28:1560-1564.
22. Kanki, P: Epidemiology and natural history of HIV-2. In AIDS: Etiology, Diagnosis, Treatment and Prevention, 4th Edn. Edited by DeVita Jr V, Hellman S, Rosenberg S. Philadelphia: JB Lippincott Co.; 1997:127-135.
23. Goudsmit J, Back NK, Nara PL: Genomic diversity and antigenic variation of HIV-1: links between pathogenesis, epidemiology and vaccine development. FASEB J 1991, 5:2427-2436.
24. Schulz TF, Whitby D, Hoad JG, Corrah T, Whittle H, Weiss RA: Biological and molecular variability of human immunodeficiency virus type 2 isolates from the Gambia. J Virol 1990, 158:1170-1176.
25. Sankalé JL, Sallier de la Tour R, Renjifo B, et al.: Intra-patient variability of the human immunodeficiency virus type-2 (HIV-2) envelope V3 loop. AIDS Res Hum Retroviruses 1995, 11:617-623.
26. Kumar U, Heredia A, Soriano V, Bravo R, Epstein JS, Hewlett IK: Enhanced diagnostic efficiency of polymerase chain reaction by co-amplification of multiple regions of HIV-1 and HIV-2. J Virol Methods 1994, 49:37-46.
27. Loussert-Ajaka I, Simon F, Farfara I, et al.: Comparative study of single and nested PCR for the detection of proviral HIV-2 DNA. Res Virol 1994, 145:357-342.
28. Simon F, Matheron S, Tamalet C, et al.: Cellular and plasma viral load in patients infected with HIV-2. AIDS 1993, 7:1411-1417.
29. Peeters M, Fransen K, Gershy-Damet GM, et al.: Effect of methodology on detection of HIV-1/HIV-2 infections in Cote d'Ivoire. J Virol Methods 1994, 48:23-30.
30. Berry N, Ariyoshi K, Jobe O, et al.: HIV type 2 proviral load measured by quantitative polymerase chain reaction correlates with CD4+ lymphopenia in HIV type 2-infected individuals. AIDS Res Hum Retroviruses 1994, 10:1031-1036.
31. Marlink R, Kanki P, Thior I, et al.: Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994, 265:1587-1590.